Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | ALAS2 CL E G H | 212 | 397 | ORPHA:75563 | X-linked sideroblastic anemia | HP:0040281 - Very frequent | | | 72 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | BCS1L CL E G H | 617 | 1020 | ORPHA:53693 | GRACILE syndrome | | | | 72 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | BCS1L CL E G H | 617 | 1020 | OMIM:603358 | GRACILE SYNDROME | | | | 72 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | BMP2 CL E G H | 650 | 1069 | OMIM:235200 | Hemochromatosis, type 1 | | | | 13 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | BMP6 CL E G H | 654 | 1073 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040281 - Very frequent | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | CARD9 CL E G H | 64170 | 16391 | OMIM:212050 | Candidiasis, familial chronic mucocutaneous, autosomal recessive | | | | 45 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | | | | 263 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | CP CL E G H | 1356 | 2295 | ORPHA:48818 | Aceruloplasminemia | | | | 115 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | CP CL E G H | 1356 | 2295 | OMIM:604290 | ACERULOPLASMINEMIA | | | | 115 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:391372 | Intellectual disability-severe speech delay-mild dysmorphism syndrome | | | | 184 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HAMP CL E G H | 57817 | 15598 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040281 - Very frequent | | | 15 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HAMP CL E G H | 57817 | 15598 | OMIM:613313 | Hemochromatosis, type 2B | | | | 15 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | HP:0040282 - Frequent | | | 580 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | HP:0040282 - Frequent | | | 580 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | HP:0040283 - Occasional | | | 580 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HFE CL E G H | 3077 | 4886 | OMIM:235200 | Hemochromatosis, type 1 | | | | 38 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040281 - Very frequent | | | 38 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HJV CL E G H | 148738 | 4887 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040281 - Very frequent | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | HJV CL E G H | 148738 | 4887 | OMIM:602390 | Hemochromatosis, type 2A | | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | KIF23 CL E G H | 9493 | 6392 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | 1 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | PIGA CL E G H | 5277 | 8957 | ORPHA:447 | Paroxysmal nocturnal hemoglobinuria | | | | 46 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | PKLR CL E G H | 5313 | 9020 | ORPHA:766 | Hemolytic anemia due to red cell pyruvate kinase deficiency | | | | 51 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | RACGAP1 CL E G H | 29127 | 9804 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SKIC2 CL E G H | 6499 | 10898 | ORPHA:84064 | Syndromic diarrhea | HP:0040283 - Occasional | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SKIC2 CL E G H | 6499 | 10898 | OMIM:614602 | Trichohepatoenteric syndrome 2 | | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SKIC3 CL E G H | 9652 | 23639 | ORPHA:84064 | Syndromic diarrhea | HP:0040283 - Occasional | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SKIC3 CL E G H | 9652 | 23639 | OMIM:222470 | Trichohepatoenteric syndrome 1 | . | | | | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SLC25A38 CL E G H | 54977 | 26054 | OMIM:205950 | Anemia, sideroblastic, 2, pyridoxine-refractory | | | | 41 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | | | | 42 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SLC30A10 CL E G H | 55532 | 25355 | OMIM:613280 | Hypermanganesemia with dystonia 1 | | | | 42 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | SLC40A1 CL E G H | 30061 | 10909 | OMIM:606069 | Hemochromatosis, type 4 | | | | 56 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | STEAP3 CL E G H | 55240 | 24592 | OMIM:615234 | Anemia, hypochromic microcytic, with iron overload 2 | | | | 1 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | STEAP3 CL E G H | 55240 | 24592 | ORPHA:300298 | Severe congenital hypochromic anemia with ringed sideroblasts | | | | 1 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011031 | HP:0011031 | Abnormality of iron homeostasis | 0 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616959 | Retinitis pigmentosa and erythrocytic microcytosis | | | | 28 | | |
HP:0011031 | HP:0033212 | Abnormal total iron binding capacity | 1 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | BCS1L CL E G H | 617 | 1020 | OMIM:603358 | GRACILE SYNDROME | | | | 72 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | BCS1L CL E G H | 617 | 1020 | ORPHA:53693 | GRACILE syndrome | | | | 72 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | BMP2 CL E G H | 650 | 1069 | OMIM:235200 | Hemochromatosis, type 1 | | | | 13 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | BMP6 CL E G H | 654 | 1073 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | | | | | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | CARD9 CL E G H | 64170 | 16391 | OMIM:212050 | Candidiasis, familial chronic mucocutaneous, autosomal recessive | | | | 45 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | | | | 263 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | CP CL E G H | 1356 | 2295 | ORPHA:48818 | Aceruloplasminemia | | | | 115 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | CP CL E G H | 1356 | 2295 | OMIM:604290 | ACERULOPLASMINEMIA | | | | 115 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:391372 | Intellectual disability-severe speech delay-mild dysmorphism syndrome | | | | 184 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | HAMP CL E G H | 57817 | 15598 | ORPHA:79230 | Hemochromatosis type 2 | | | | 15 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | HAMP CL E G H | 57817 | 15598 | OMIM:613313 | Hemochromatosis, type 2B | | | | 15 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | HAMP CL E G H | 57817 | 15598 | OMIM:613313 | Hemochromatosis, type 2B | | | | 15 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | HFE CL E G H | 3077 | 4886 | OMIM:235200 | Hemochromatosis, type 1 | | | | 38 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | HFE CL E G H | 3077 | 4886 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | | | | 38 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | HJV CL E G H | 148738 | 4887 | ORPHA:79230 | Hemochromatosis type 2 | | | | | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | HJV CL E G H | 148738 | 4887 | OMIM:602390 | Hemochromatosis, type 2A | | | | | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | KIF23 CL E G H | 9493 | 6392 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | 1 | | |
HP:0011031 | HP:0033212 | Abnormal total iron binding capacity | 1 | KIF23 CL E G H | 9493 | 6392 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | 1 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | PIGA CL E G H | 5277 | 8957 | ORPHA:447 | Paroxysmal nocturnal hemoglobinuria | | | | 46 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | PKLR CL E G H | 5313 | 9020 | ORPHA:766 | Hemolytic anemia due to red cell pyruvate kinase deficiency | | | | 51 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | PKLR CL E G H | 5313 | 9020 | ORPHA:766 | Hemolytic anemia due to red cell pyruvate kinase deficiency | | | | 51 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | RACGAP1 CL E G H | 29127 | 9804 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | | | |
HP:0011031 | HP:0033212 | Abnormal total iron binding capacity | 1 | RACGAP1 CL E G H | 29127 | 9804 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | | | | | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | SKIC2 CL E G H | 6499 | 10898 | OMIM:614602 | Trichohepatoenteric syndrome 2 | | | | | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | SKIC3 CL E G H | 9652 | 23639 | OMIM:222470 | Trichohepatoenteric syndrome 1 | | | | | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | SLC25A38 CL E G H | 54977 | 26054 | OMIM:205950 | Anemia, sideroblastic, 2, pyridoxine-refractory | | | | 41 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | HP:0040282 - Frequent | | | 42 | | |
HP:0011031 | HP:0033212 | Abnormal total iron binding capacity | 1 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | | | | 42 | | |
HP:0011031 | HP:0033212 | Abnormal total iron binding capacity | 1 | SLC30A10 CL E G H | 55532 | 25355 | OMIM:613280 | Hypermanganesemia with dystonia 1 | | | | 42 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | SLC40A1 CL E G H | 30061 | 10909 | OMIM:606069 | Hemochromatosis, type 4 | | | | 56 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | STEAP3 CL E G H | 55240 | 24592 | OMIM:615234 | Anemia, hypochromic microcytic, with iron overload 2 | | | | 1 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | STEAP3 CL E G H | 55240 | 24592 | ORPHA:300298 | Severe congenital hypochromic anemia with ringed sideroblasts | | | | 1 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | STEAP3 CL E G H | 55240 | 24592 | ORPHA:300298 | Severe congenital hypochromic anemia with ringed sideroblasts | | | | 1 | | |
HP:0011031 | HP:0040135 | Abnormal transferrin saturation | 1 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011031 | HP:0040130 | Abnormal serum iron concentration | 1 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616959 | Retinitis pigmentosa and erythrocytic microcytosis | | | | 28 | | |
HP:0011031 | HP:0033211 | Decreased total iron binding capacity | 2 | CL E G H | | | | | | | | | | |
HP:0011031 | HP:0025196 | Increased total iron binding capacity | 2 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0011031 | HP:0012464 | Decreased transferrin saturation | 2 | BCS1L CL E G H | 617 | 1020 | ORPHA:53693 | GRACILE syndrome | HP:0040281 - Very frequent | | | 72 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | BCS1L CL E G H | 617 | 1020 | OMIM:603358 | GRACILE SYNDROME | | | | 72 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | BMP2 CL E G H | 650 | 1069 | OMIM:235200 | Hemochromatosis, type 1 | . | | | 13 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | BMP6 CL E G H | 654 | 1073 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040281 - Very frequent | | | | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | CARD9 CL E G H | 64170 | 16391 | OMIM:212050 | Candidiasis, familial chronic mucocutaneous, autosomal recessive | | | | 45 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | HP:0040282 - Frequent | | | 263 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | CP CL E G H | 1356 | 2295 | ORPHA:48818 | Aceruloplasminemia | HP:0040282 - Frequent | | | 115 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | CP CL E G H | 1356 | 2295 | OMIM:604290 | ACERULOPLASMINEMIA | . | | | 115 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | FOXP1 CL E G H | 27086 | 3823 | ORPHA:391372 | Intellectual disability-severe speech delay-mild dysmorphism syndrome | HP:0040283 - Occasional | | | 184 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | HAMP CL E G H | 57817 | 15598 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040281 - Very frequent | | | 15 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | HAMP CL E G H | 57817 | 15598 | OMIM:613313 | Hemochromatosis, type 2B | | | | 15 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | HAMP CL E G H | 57817 | 15598 | OMIM:613313 | Hemochromatosis, type 2B | . | | | 15 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | HFE CL E G H | 3077 | 4886 | OMIM:235200 | Hemochromatosis, type 1 | . | | | 38 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | HFE CL E G H | 3077 | 4886 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040281 - Very frequent | | | 38 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | HJV CL E G H | 148738 | 4887 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040281 - Very frequent | | | | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | HJV CL E G H | 148738 | 4887 | OMIM:602390 | Hemochromatosis, type 2A | | | | | | |
HP:0011031 | HP:0025196 | Increased total iron binding capacity | 2 | KIF23 CL E G H | 9493 | 6392 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | HP:0040282 - Frequent | | | 1 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | KIF23 CL E G H | 9493 | 6392 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | HP:0040282 - Frequent | | | 1 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | PIGA CL E G H | 5277 | 8957 | ORPHA:447 | Paroxysmal nocturnal hemoglobinuria | HP:0040282 - Frequent | | | 46 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | PKLR CL E G H | 5313 | 9020 | ORPHA:766 | Hemolytic anemia due to red cell pyruvate kinase deficiency | HP:0040282 - Frequent | | | 51 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | PKLR CL E G H | 5313 | 9020 | ORPHA:766 | Hemolytic anemia due to red cell pyruvate kinase deficiency | HP:0040283 - Occasional | | | 51 | | |
HP:0011031 | HP:0025196 | Increased total iron binding capacity | 2 | RACGAP1 CL E G H | 29127 | 9804 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | HP:0040282 - Frequent | | | | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | RACGAP1 CL E G H | 29127 | 9804 | ORPHA:98870 | Congenital dyserythropoietic anemia type III | HP:0040282 - Frequent | | | | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | SKIC2 CL E G H | 6499 | 10898 | OMIM:614602 | Trichohepatoenteric syndrome 2 | HP:0040283 - Occasional | | | | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | SKIC3 CL E G H | 9652 | 23639 | OMIM:222470 | Trichohepatoenteric syndrome 1 | . | HP:0003577 - Congenital onset | | | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | SLC25A38 CL E G H | 54977 | 26054 | OMIM:205950 | Anemia, sideroblastic, 2, pyridoxine-refractory | | | | 41 | | |
HP:0011031 | HP:0025196 | Increased total iron binding capacity | 2 | SLC30A10 CL E G H | 55532 | 25355 | ORPHA:309854 | Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome | HP:0040283 - Occasional | | | 42 | | |
HP:0011031 | HP:0025196 | Increased total iron binding capacity | 2 | SLC30A10 CL E G H | 55532 | 25355 | OMIM:613280 | Hypermanganesemia with dystonia 1 | | | | 42 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | SLC40A1 CL E G H | 30061 | 10909 | OMIM:606069 | Hemochromatosis, type 4 | | | | 56 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | STEAP3 CL E G H | 55240 | 24592 | OMIM:615234 | Anemia, hypochromic microcytic, with iron overload 2 | | | | 1 | | |
HP:0011031 | HP:0012464 | Decreased transferrin saturation | 2 | STEAP3 CL E G H | 55240 | 24592 | ORPHA:300298 | Severe congenital hypochromic anemia with ringed sideroblasts | HP:0040281 - Very frequent | | | 1 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | STEAP3 CL E G H | 55240 | 24592 | ORPHA:300298 | Severe congenital hypochromic anemia with ringed sideroblasts | HP:0040282 - Frequent | | | 1 | | |
HP:0011031 | HP:0003452 | Increased serum iron | 2 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | . | | | 67 | | |
HP:0011031 | HP:0012463 | Elevated transferrin saturation | 2 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011031 | HP:0040303 | Decreased serum iron | 2 | TRNT1 CL E G H | 51095 | 17341 | OMIM:616959 | Retinitis pigmentosa and erythrocytic microcytosis | | | | 28 | | |